Key result
Intravenous administration of D-sotalol, terfenadine, and chromanol 293B prolonged the QT interval by 32 ms, 23 ms, and 33 ms respectively in halothane-anaesthetized guinea-pigs.
Halothane-anaesthetized guinea-pigs serve as a sensitive in vivo model for detecting drug-induced QT interval prolongation due to reduced repolarization reserve.
Answers are grounded in this paper and cite their sources.
Supports halothane-anaesthetized guinea-pigs as a sensitive QT-prolongation model; leaves open clinical translation.
The utility of halothane-anaesthetized guinea-pigs as an in vivo model for predicting the clinical potential of a drug to induce QT interval prolongation was assessed using the electrocardiogram and monophasic action potential (MAP) recordings with electrical ventricular pacing. Intravenous administration of D-sotalol (0.3 mg kg(-1)) and terfenadine (0.3 mg kg(-1)), blockers of a rapid component of delayed rectifier potassium currents, prolonged the QT interval by 32+/-7 and 23+/-6 ms, respectively, whereas chromanol 293B (1 mg kg(-1)), a blocker of a slow component of delayed rectifier potassium currents, lengthened it by 33+/-8 ms. The extent of the QT interval prolongation by these drugs was greater than those in previous reports using pentobarbital-anaesthetized guinea-pigs. The MAP duration at the control was shortened by decreasing the pacing cycle length from 400 to 200 ms, but the MAP duration at each cycle length was prolonged by D-sotalol. The formulas of Van de Water, Matsunaga, Fridericia and Bazett showed good correlation of the repolarization period when compared with the MAP duration at a pacing cycle length of 400 ms. The halothane-anaesthetized guinea-pig model may possess enough sensitivity to detect drug-induced QT interval prolongation, indicating that halothane anaesthesia can reduce the repolarization reserve of the heart in vivo.
No takes yet. Share an insight, caveat, or question.
Takahara et al. (2005) studied Drug-induced QT interval prolongation (n=18). D-sotalol, terfenadine, and chromanol 293B vs. Predrug baseline was evaluated on QT interval prolongation (32±7 ms (D-sotalol), 23±6 ms (terfenadine), 33±8 ms (chromanol 293B), p=<0.05). Intravenous administration of D-sotalol, terfenadine, and chromanol 293B prolonged the QT interval by 32 ms, 23 ms, and 33 ms respectively in halothane-anaesthetized guinea-pigs.
Synapse has enriched 10 related papers. Consider them for comparative context: